Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jan 22.
Published in final edited form as: J Am Chem Soc. 2018 Jun 19;140(26):8105–8109. doi: 10.1021/jacs.8b05043

A Benzyne Insertion Approach to Hetisine-Type Diterpenoid Alkaloids: Synthesis of Cossonidine (Davisine)

Kevin G M Kou †,#, Jason J Pflueger †,§,#, Toshihiro Kiho †,, Louis C Morrill †,, Ethan L Fisher †,, Kyle Clagg †,, Terry P Lebold †,°, Jessica K Kisunzu Δ,*, Richmond Sarpong †,*
PMCID: PMC6342194  NIHMSID: NIHMS995010  PMID: 29889509

Abstract

The hetisine-type natural products exhibit one of the most complex carbon skeletons within the diterpenoid alkaloid family. The use of network analysis has enabled a synthesis strategy to access alkaloids in this class with hydroxylation on the A-ring. Key transformations include a benzyne acyl-alkylation to construct a key fused 6–7-6 tricycle, a chemoselective nitrile reduction, and sequential C–N bond formations using a reductive cyclization and a photochemical hydroamination to construct an embedded azabicycle. Our strategy should enable access to myriad natural and unnatural products within the hetisine-type.


Voltage-gated sodium (Nav), calcium (Cav), and potassium (Kv) channels regulate a wide variety of biophysical responses in the nervous, circulatory, and muscular systems.1 As a result, the selective targeting of ion channels holds great promise for treating a number of channelopathies, including Alzheimer’s disease, epilepsy, and chronic pain.2 One of the greatest challenges in the discovery of small molecule modulators of ion channels, particularly Nav channels, is to achieve high selectivity in targeting one isoform over another.3 For example, targeting Nav1.7 or 1.8 may prove useful in combating chronic pain, but off-target interaction with other isoforms leads to serious cognitive, cardiac, or muscular complications.3a The identification, synthesis, and study of isoform-selective ion channel modulators will facilitate a better understanding of the interactions responsible for selectivity.

The diterpenoid alkaloids, a collection of over 1200 natural products isolated from numerous plants in the Aconitum, Delphinium, and Consolida genera, show strong affinities for various Nav and Kv channels, functioning as either agonists or antagonists.4 This broad range of activity and selectivity arises from relatively subtle changes on scaffolds consisting of 18, 19, and 20 carbon atoms. For example, despite their overwhelming similarities, the C19-diterpenoid alkaloid aconitine (1, Figure 1) is a potent Nav channel activator, whereas the related C18-diterpenoid alkaloid lappaconitine (2) is a Nav channel blocker.5 The C20-diterpenoid alkaloid Guan-fu base A (3), another Nav channel blocker, is approved and marketed in China for the treatment of arrhythmia.6 Within this family, there exist other oxygenated congeners with unexplored activity.7 Therefore, the ability to access myriad oxygenated diterpenoid alkaloid natural products and their associated derivatives would enable studies to deepen our understanding of the structure–activity relationships across all classes and types.

Figure 1.

Figure 1.

Representative diterpenoid alkaloids.

Our group’s interest in this class of molecules has culminated in the syntheses of several C18- and C19-aconitine-type, as well as C20-denudatine-type natural products.8,9 Within the C20 family, the hetisine-type molecules are the most prevalent, with more than 120 known members, including Guan-fu base A (3).10 Of the biosynthetically related atisine-, denudatine-, hetidine-, hetisine-, and vakognavine-type natural products (Figure 2), the carbon framework of the hetisine-type diterpenoid alkaloids (exemplified by cossonidine (8)) is considered to be the most complex, featuring a C14–C20 bond and an N–C6 bond, which results in a tertiary amine embedded within a heptacyclic skeleton. Strategies for the syntheses of atisine- and hetidine-type diterpenoid alkaloids have been advanced;1115 however, to date, only monohydroxylated hetisine-type alkaloids have been accessed by total synthesis: nominine (4) by Muratake/Natsume16a–c as well as by Gin/Peese,16e,f and spirasine IV/XI by Zhang and coworkers.17 The relatively few number of hetisine syntheses can, in part, be attributed to the challenge in forming the N–C6 bond at a late stage through chemical synthesis.11a,13

Figure 2.

Figure 2.

Biosynthetic relationships between selected C20-diterpenoid alkaloids.

Cognizant of the fact that most hetisine-type diterpenoid alkaloids, including the medicinally relevant Guan-fu base A (3), possess additional oxygenation on the A ring, our group set out to develop a synthesis route to the hetisine framework that would introduce A ring oxygenation, while obviating the challenge associated with a late-stage installation of the N–C6 bond. In this Communication, we report a validation of our approach, which has resulted in the first synthesis of cossonidine (8), a hetisine-type alkaloid isolated independently in 1996 by de la Fuente7b and Pelletier7c (who termed this natural product davisine).

By constraining our analysis to a maximum ring size of seven in our network-analysis of cossonidine (8),18,19 we identified two maximally bridged ring systems: a carbocyclic 7-membered ring and a nitrogen-containing 7-membered ring (highlighted in blue, Scheme 1), both of which contain 6 bridging atoms. To achieve maximal simplification of the highlighted bridged ring systems, we envisioned a bicyclization transform that would alleviate bridging atoms in both ring systems, thus leading back to pentacycle 9 containing an alkene and arene functional groups. Network analysis of 9 revealed the F ring to be maximally bridged, with 5 bridging atoms. Disconnecting the two C–N bonds in 9 using two amination transforms effectively simplified the target structure to fused tricycle 10, which exhibits no bridging elements. Forging the seven-membered ring motif in 10 was envisioned to occur through an acyl-alkylation annulation between functionalized benzyne derivative 11 and β-ketoester 12, which in turn could arise from literature-reported hydrindanone 13.8,9

Scheme 1.

Scheme 1.

Network-Analysis-Guided Retrosynthesis of Cossonidine

Hydrindanone 13, prepared on multigram scale in two steps from dienophile 14 and diene 15 according to our previously reported procedures,8,9 served as the starting point for our studies (see Scheme 2). LiAlH4-mediated reduction of both the ester and ketone groups in 13, followed by Ley oxidation,20 provided a ketoaldehyde intermediate (not shown). While olefination of the aldehyde under standard Wittig conditions led to poor yields of the desired alkene, application of Lebel’s Rh-catalyzed methylenation21 effected selective formation of terminal alkene 16 in 71% yield over 3 steps. Acylation using allyl cyanoformate (17)22 proceeded in 88% yield to provide β-ketoester 12, the substrate for the aryne insertion reaction. Following the precedent of Stoltz and co-workers,23 treatment of a mixture of β-ketoester 12 and aryne precursor 1824 with CsF in MeCN at 70 °C provided tricycle 19 in 38–45% yields. The bromine atom on the aryne was required to obtain high regioselectivity in the acyl-alkylation process, in accordance with studies by Garg and Houk.25 This transformation represents one of the most complex applications of the benzyne acyl-alkylation reaction reported to date.26

Scheme 2.

Scheme 2.

Synthesis and Elaboration of the 6–7-6 Tricycle

We next sought to install a functional handle in the form of an alkene group at C6 to aid in the formation of the N–C6 bond at a later stage of the synthesis. Thus, deallylation using catalytic Pd(PPh3)4 and PhSiH3 provided carboxylic acid 20 in 98% yield,27 which was characterized by X-ray crystallography. Subsequent treatment with 1,3-diiodo-5,5-dimethylhydantoin (DIH) under photochemical conditions effected oxidative decarboxylation28 to furnish styrenyl derivative 21 in 74% yield.

The next challenge was to introduce the methyl group (C18) at the C4-position, which is present not only in the hetisine-type but also in all the C20-diterpenoid alkaloid natural products. Efforts to introduce this methyl group at earlier stages in the synthesis were unsuccessful, resulting in recovered starting material or nonspecific decomposition. Ultimately, the primary hydroxyl group resulting from TBAF-mediated desilylation of 21 (95% yield) was directly converted into nitrile 22 in 96% yield,29 and diastereoselective methylation of 22 was accomplished in 58% yield by deprotonation with LiHMDS followed by addition of methyl iodide. Access to tricyclic intermediate 10, bearing functional handles at C6 and C20, set the stage for the subsequent C–N bond-forming reactions.

To construct the azabicycle moiety, we sought to first form the N–C20 bond through a global reduction of 10, which we envisioned would convert the nitrile to a primary amine, the ketone to a hydroxyl group, and effect removal of the bromine atom. At this stage, displacement of the C20-hydroxyl group by the resultant primary amine through a Mitsunobu reaction or via an intermediate alkyl chloride was envisioned to forge the piperidine ring (the N–C20 bond).12b However, treatment of 10 with LiAlH4 resulted in a complex mixture of products, potentially due to incomplete reduction of the nitrile group. With this in mind, we posited that a plausible solution would be to first chemoselectively reduce the nitrile group in the presence of the ketone carbonyl and two alkene groups. Gratifyingly, this was achieved with cobalt boride (Co2B) and borane t-butylamine complex (Scheme 3).30 With the primary amine in hand, treatment with LiAlH4 in refluxing THF allowed for ketone reduction, protodebromination, and unexpected direct cyclization to form the N–C20 bond, delivering secondary amine 23. A photochemical hydroamination furnished tertiary amine 9 in 71% yield over 3 steps.31

Scheme 3.

Scheme 3.

Assembly of the Heptacyclic Core of the Hetisine-Type Alkaloids and Completion of Cossonidine

At this stage, formation of the [2.2.2] bicycle was explored following the Birch reduction/intramolecular Diels–Alder sequence utilized in the Gin synthesis of nominine.17 Notably, while the cycloaddition performed by Gin and Peese (on an intermediate analogous to 24 but lacking the C1-methoxy substituent) proceeded in high yield at only 60 °C, the cycloaddition of 24 required significantly elevated temperatures. The best results were achieved using microwave irradiation at 110 °C in 9:1 MeOH/pyrrolidine for 2 h, forging the heptacyclic product (25) after hydrolysis in 54% yield over 2 steps. We postulate that the steric influence of the equatorial C1-methoxy substituent in 24 preferentially orients the vinyl group away from the diene, a penalty that is avoided in the Gin substrate lacking the methoxy group.

With the heptacyclic core assembled, we investigated reaction conditions for selective cleavage of the C1 methyl ether. While an evaluation of standard Lewis acid-mediated conditions for the cleavage of aliphatic methyl ethers proved unsuccessful, exposure of ether 25 to HBr in AcOH9,32 and ensuing treatment with K2CO3 in methanol provided secondary alcohol 26 in 60% yield over 2 steps. Under these conditions, a Wagner–Meerwein rearrangement product (27), which was umambiguously characterized by X-ray crystallography, is also formed in 5% yield over 2 steps (see the SI for details). Wittig methylenation converted the ketone group of 26 into the terminal alkene (28) in 85% yield, thereby introducing the final carbon atom of the hetisine-type skeleton. An oxidation/reduction sequence was then explored to invert the C1-stereocenter. Application of Stahl’s aerobic oxidation conditions33 gave the ketone 29 in 81% yield. In a reversal of the typical stereoselectivity trend observed in cyclohexanone reductions,34 reacting this ketone with LiAlH4 resulted in a diastereoselective reduction (6.6:1 dr) in favor of the desired alcohol (30) with the axially disposed hydroxyl group, which was isolated in 81% yield. Subjecting 30 to selenium dioxide produced cossonidine (8) and enone 31 in 39% and 19% yields, respectively. Reduction of enone 31 under Luche conditions resulted in 90% yield of a 3:1 mixture of diastereomers favoring 15-epi-cossonidine (32).

In summary, our work has provided access to the complete hetisine-type skeleton bearing key functional group handles on both the A ring and the [2.2.2] bicycle for further derivatization. This route proceeds in 21 steps from known hydrindanone 13 and features a benzyne acyl-alkylation ring expansion, a chemoselective nitrile reduction, a light-mediated hydroamination, and an intramolecular Diels–Alder cycloaddition as key steps. With the complex hetisine skeleton assembled, future studies will be directed toward generating more highly oxygenated congeners.7 Furthermore, by starting with enantioenriched hydrindanone 13, which was recently reported by our group,8,9 this synthesis should be readily rendered enantioselective.

Supplementary Material

Supporting Information

ACKNOWLEDGMENTS

We are grateful to the NIH (NIGMS R01 GM084906) and Daiichi Sankyo (T.K.) for financial support. K.G.M.K. and T.P.L. acknowledge NSERC for postdoctoral fellowships. We are thankful to the NSF for a graduate fellowship to J.J.P. and to Eli Lilly for graduate fellowships to J.J.P. and J.K.K. We thank A. DiPasquale (UC Berkeley) for solving the crystal structure of 20 and N. Settineri (UC Berkeley) for the crystal structure of 27, supported by the NIH Shared Instrumentation Grant (S10RR027172). We thank the Central California 900 MHz NMR Facility and the College of Chemistry NMR Facilities for their help with NMR experimentation. Funds for the 900 MHz NMR spectrometer were provided by the NIH through grant GM68933. We thank Prof. Hélène Lebel̀ (U. de Montréal) for insightful conversations regarding the Rh-catalyzed olefination, and Dr. Pamela Tadross (Caltech), Prof. Brian Stoltz (Caltech), and Prof. Neil Garg (UCLA) for discussions regarding the benzyne acyl-alkylation.

Footnotes

The authors declare no competing financial interest.

ASSOCIATED CONTENT

Supporting Information

The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/jacs.8b05043.

Experimental details and spectroscopic data (PDF)

Crystallographic data for 20 (CIF)

Crystallographic data for 27 (CIF)

REFERENCES

  • (1).Yu FH; Catterall WA Sci. Signaling 2004, 2004, re15–1–re15–17. [DOI] [PubMed] [Google Scholar]
  • (2).(a) Rangaraju S; Gearing M; Jin L-W; Levey A J. Alzheimer’s Dis 2015, 44, 797–808. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Catterall WA; Kalume F; Oakley JC J. Physiol 2010, 588, 1849–1859. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Dib-Hajj SD; Yang Y; Black JA; Waxman SG Nat. Rev. Neurosci 2013, 14, 49–62. [DOI] [PubMed] [Google Scholar]; (d) Camerino DC; Tricarico D; Desaphy J-F Neurotherapeutics 2007, 4, 184–198. [DOI] [PubMed] [Google Scholar]
  • (3).(a) Ahuja S; Mukund S; Deng L; Khakh K; Chang E; Ho H; Shriver S; Young C; Lin S; Johnson JP Jr.; Wu P; Li J; Coons M; Tam C; Brillantes B; Sampang H; Mortara K; Bowman KK; Clark KR; Estevez A; Xie Z; Verschoof H; Grimwood M; Dehnhardt C; Andrez J-C; Focken T; Sutherlin DP; Safina BS; Starovasnik MA; Ortwine DF; Franke Y; Cohen CJ; Hackos DH; Koth CM; Payandeh, J. Science 2015, 350, aac5464–1–aac5464–9. [DOI] [PubMed] [Google Scholar]; (b) Osteen JD; Herzig V; Gilchrist J; Emrick JJ; Zhang C; Wang X; Castro J; Gar-cia-Caraballo S; Grundy L; Rychkov GY; Weyer AD; Dekan Z; Undheim EAB; Alewood P; Stucky CL; Brierley SM; Basbaum AI; Bosmans F; King GF; Julius D Nature 2016, 534, 494–499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (4).Ameri A Prog. Neurobiol 1998, 56, 211–235. [DOI] [PubMed] [Google Scholar]
  • (5).Tikhonov DB; Zhorov BS FEBS Lett. 2005, 579, 4207–4212. [DOI] [PubMed] [Google Scholar]
  • (6).(a) Huang X; Yang Y; Zhu J; Dai Y; Pu, J. Basic Clin. Pharmacol. Toxicol 2009, 104, 145–154. [DOI] [PubMed] [Google Scholar]; (b) Huang X; Yang Y; Zhu J; Xu D; Peng J; Liu J J. Cardiovasc. Pharmacol 2012, 59, 77–83. [DOI] [PubMed] [Google Scholar]
  • (7).For selected examples of oxygenated, C20 hetisine-type diterpenoid alkaloids, see: Pelletier SW; Page SW; Newton MG Tetrahedron Lett. 1971, 12, 795–797. Reina M; Gavín JA; Madinaveitia A; Acosta RD; de la Fuente G J. Nat. Prod 1996, 59, 145–147. Ulubelen A; Desai HK; Srivastava SK; Hart BP; Park J-C; Joshi BS; Pelletier SW; Meriçli AH; Meriç li F; Ilarslan R J. Nat. Prod 1996, 59, 360–366. Grandez M; Madinaveitia A; Gavin JA; Alva A; de la Fuente G J. Nat. Prod 2002, 65, 513–516.
  • (8).Marth CJ; Gallego GM; Lee JC; Lebold TP; Kulyk S; Kou KGM; Qin J; Lilien R; Sarpong R Nature 2015, 528, 493–498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).(a) Kou KGM; Li BX; Lee JC; Gallego GM; Lebold TP; DiPasquale AG; Sarpong R J. Am. Chem. Soc 2016, 138, 10830–10833. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Kou KGM; Kulyk S; Marth CJ; Lee JC; Doering NA; Li BX; Gallego GM; Lebold TP; Sarpong R J. Am. Chem. Soc 2017, 139, 13882–13896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (10).(a) Wang F-P; Liang X-T. In The Alkaloids: Chemistry and Biology; Cordell GA, Ed.; Elsevier Science, 2002; Vol. 59, pp 1–280. [DOI] [PubMed] [Google Scholar]; (b) Wang F-P; Chen Q-H; Liu X-Y Nat. Prod. Rep 2010, 27, 529–570. [DOI] [PubMed] [Google Scholar]
  • (11).For reviews on diterpenoid alkaloid syntheses, see: Hamlin AM; Kisunzu JK; Sarpong R Org. Biomol. Chem 2014, 12, 1846–1860. Liu X-Y; Qin Y Asian J. Org. Chem 2015, 4, 1010–1019. Zhu G; Liu R; Liu B Synthesis 2015, 47, 2691–2708. Liu X-Y; Qin Y Nat. Prod. Rep 2017, 34, 1044–1050.
  • (12).(a) Hamlin AM; de Jesus Cortez F; Lapointe D; Sarpong R Angew. Chem., Int. Ed 2013, 52, 4854–4857. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Hamlin AM; Lapointe D; Owens K; Sarpong R J. Org. Chem 2014, 79, 6783–6800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (13).Cherney EC; Lopchuk JM; Green JC; Baran PS J. Am. Chem. Soc 2014, 136, 12592–12595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Liu J; Ma D Angew. Chem., Int. Ed 2018, 57, 6676–6680. [DOI] [PubMed] [Google Scholar]
  • (15).Zhou S; Guo R; Yang P; Li A J. Am. Chem. Soc 2018, Just Accepted. DOI: 10.1021/jacs.8b03712. [DOI] [PubMed] [Google Scholar]
  • (16).(a) Muratake H; Natsume M Angew. Chem., Int. Ed 2004, 43, 4646–4649. [DOI] [PubMed] [Google Scholar]; (b) Muratake H; Natsume M Tetrahedron 2006, 62, 7056–7070. [Google Scholar]; (c) Muratake H; Natsume M Tetrahedron 2006, 62, 7071–7072. [Google Scholar]; (d) Muratake H; Natsume M; Nakai H Tetrahedron 2006, 62, 7093–7112. [Google Scholar]; (e) Peese KM; Gin DY J. Am. Chem. Soc 2006, 128, 8734–8735. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Peese KM; Gin DY Chem. - Eur. J 2008, 14, 1654–1665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Zhang Q; Zhang Z; Huang Z; Zhang C; Xi S; Zhang M Angew. Chem., Int. Ed 2018, 57, 937–941. [DOI] [PubMed] [Google Scholar]
  • (18).Corey EJ; Howe WJ; Orf HW; Pensak DA; Petersson G J. Am. Chem. Soc 1975, 97, 6116–6124. [Google Scholar]
  • (19).For discussions of network analysis applied to terpenoid alkaloids, see: Heathcock CH Angew. Chem., Int. Ed. Engl 1992, 31, 665–681. Refs 8 and 9b.
  • (20).Griffith WP; Ley SV; Whitcombe GP; White AD J. Chem. Soc., Chem. Commun 1987, 1625–1627. [Google Scholar]
  • (21).Lebel H; Paquet V J. Am. Chem. Soc 2004, 126, 320–328. [DOI] [PubMed] [Google Scholar]
  • (22).Donnelly DMX; Finet J-P; Rattigan BA J. Chem. Soc., Perkin Trans. 1 1993, 1729–1735. [Google Scholar]
  • (23).Tambar UK; Stoltz BM J. Am. Chem. Soc 2005, 127, 5340–5341. [DOI] [PubMed] [Google Scholar]
  • (24).Bronner SM; Goetz AE; Garg NK J. Am. Chem. Soc 2011, 133, 3832–3835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Medina JM; Mackey JL; Garg NK; Houk KN J. Am. Chem. Soc 2014, 136, 15798–15805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (26).Tadross PM; Stoltz BM Chem. Rev 2012, 112, 3550–2577. [DOI] [PubMed] [Google Scholar]
  • (27).Dessolin M; Guillerez M-G; Thieriet N; Guibé F; Loffet A Tetrahedron Lett. 1995, 36, 5741–5744. [Google Scholar]
  • (28).Kulbitski K; Nisnevich G; Gandelman M Adv. Synth. Catal 2011, 353, 1438–1442. [Google Scholar]
  • (29).Vatelè J-M Synlett 2014, 25, 1275–1278. [Google Scholar]
  • (30).Heinzman SW; Ganem BJ Am. Chem. Soc 1982, 104, 6801–6802. [Google Scholar]
  • (31).Trost BM; Tang WJ Am. Chem. Soc 2002, 124, 14542–14543. [DOI] [PubMed] [Google Scholar]
  • (32).Tang P; Chen Q-F; Wang L; Chen Q-H; Jian X-X; Wang F-P Tetrahedron 2012, 68, 5668–5676. [Google Scholar]
  • (33).Steves JE; Stahl SS J. Am. Chem. Soc 2013, 135, 15742–15745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (34).Comprehensive Organic Synthesis; Trost BM., Fleming I, Eds.; Elsevier: Oxford, U. K., 1991; Vol. 8, Section 1.1. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES